Categories
Senores Pharmaceuticals Limited — Updates, 14-05-2026: Press Release
14-05-2026 · 02:28 pm
Senores Pharma reported robust Q4 & FY26 results with PAT up 104% & 108% YoY. Growth drivers include strong Regulated Markets performance, 51 approved ANDAs, and strategic moves: acquiring Zoraya & Apnar Pharma, plus a US federal market JV.
No comments yet. Be the first to comment!